Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chelluboina, Bharath ^a   Warhekar, Aditi ^a   Dillard, Matt ^a   Klopfenstein, Jeffrey D ^a,b   Pinson, David M ^a   Wang, David Z ^a,b   Veeravalli, Krishna Kumar ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Department of Neurosurgery University of Illinois College of Medicine at Peoria ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MACROPHAGE ELASTASE; MYELIN BASIC PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR;

ANIMAL; APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; DRUG EFFECTS; ENZYME SPECIFICITY; ENZYMOLOGY; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; NERVE CELL; PATHOLOGY; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN INJURIES; BRAIN ISCHEMIA; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; MALE; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 9; MYELIN BASIC PROTEIN; NEURONS; PLASMIDS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION; RNA, SMALL INTERFERING; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84929104372     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09504     Document Type: Article

References (41)

1. Banerjee, S., Williamson, D., Habib, N., Gordon, M. & Chataway, J. Human stem cell therapy in ischaemic stroke: a review. Age Ageing 40, 7-13 (2011).
2. del Zoppo, G. J. tPA: a neuron buster, too? Nat. Med. 4, 148-150 (1998).
3. Hacke, W. et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53, S3-14 (1999).
4. Wang, X. et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9, 1313-1317 (2003).
5. Gasche, Y. et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19, 1020-1028 (1999).
6. Heo, J. H. et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624-633 (1999).
7. Mun-Bryce, S. & Rosenberg, G. A. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172 (1998).
8. Asahi, M. et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732 (2001).
9. Lo, E. H., Dalkara, T. & Moskowitz, M. A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415 (2003).
10. Lo, E. H., Broderick, J. P. & Moskowitz, M. A. tPA and proteolysis in the neurovascular unit. Stroke 35, 354-356 (2004).
11. Pfefferkorn, T. & Rosenberg, G. A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34, 2025-2030 (2003).
12. Lee, S. R. & Lo, E. H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24, 720-727 (2004).
13. Gu, Z. et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25, 6401-6408 (2005).
14. Matsumoto, S. et al. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am. J. Pathol. 153, 109-119 (1998).
15. Chandler, S., Cossins, J., Lury, J. &Wells, G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 228, 421-429 (1996).
16. Belaaouaj, A. A., Li, A., Wun, T. C., Welgus, H. G. & Shapiro, S. D. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J. Biol. Chem. 275, 27123-27128 (2000).
17. Dong, Z., Kumar, R., Yang, X.&Fidler, I. J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810 (1997).
18. Cornelius, L. A. et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161, 6845-6852 (1998).
19. Dwivedi, A. & George, S. MMP-12 is important for VSMC proliferation and migration: role of B-catenin signalling. Vascul Pharmacol 45, e129 (2006).
20. Wells, J. E. et al. Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice. Eur. J. Neurosci. 21, 187-196 (2005).
21. Svedin, P., Hagberg, H. & Mallard, C. Expression of MMP-12 after neonatal hypoxic-ischemic brain injury in mice. Dev. Neurosci. 31, 427-436 (2009).
22. Romanic, A. M., White, R. F., Arleth, A. J., Ohlstein, E. H. & Barone, F. C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29, 1020-1030 (1998).
23. Montaner, J. et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32, 1759-1766 (2001).
24. Svedin, P., Hagberg, H., Savman, K., Zhu, C. & Mallard, C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J. Neurosci. 27, 1511-1518 (2007).
25. Hu, Q. et al. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp. Neurol. 216, 35-46 (2009).
26. Bonoiu, A. et al. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res. 1282, 142-155 (2009).
27. Hu, Q. et al. Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats. Brain Res. 1367, 347-359 (2011).
28. Mahajan, S. D. et al. Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex. Immunol. Invest 41, 337-355 (2012).
29. Power, C. et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53, 731-742 (2003).
30. Wasserman, J. K., Zhu, X. & Schlichter, L. C. Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res. 1180, 140-154 (2007).
31. Gronski, T. J., Jr et al. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 272, 12189-12194 (1997).
32. Liu, Y. et al. Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain. Neurobiol. Aging 34, 1231-1239 (2013).
33. Yong, V. W., Power, C., Forsyth, P. & Edwards, D. R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511 (2001).
34. Churg, A. et al. Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am. J. Respir. Cell Mol. Biol. 27, 368-374 (2002).
35. Larsen, P. H. & Yong, V. W. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. J. Neurosci. 24, 7597-7603 (2004).
36. Larsen, P. H., DaSilva, A. G., Conant, K. & Yong, V. W. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and-12 null mice. J. Neurosci. 26, 2207-2214 (2006).
37. Vos, C. M., van Haastert, E. S., de Groot, C. J., van der Valk, P. & de Vries, H. E. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J. Neuroimmunol. 138, 106-114 (2003).
38. Ulrich, R. et al. MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis. J. Neuropathol. Exp. Neurol. 65, 783-793 (2006).
39. Lanone, S. et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and-12 in IL-13-induced inflammation and remodeling. J. Clin. Invest 110, 463-474 (2002).
40. Chelluboina, B., Klopfenstein, J. D., Gujrati, M., Rao, J. S. & Veeravalli, K. K. Temporal regulation of apoptotic and anti-apoptotic molecules after middle cerebral artery occlusion followed by reperfusion. Mol. Neurobiol. 49, 50-65 (2014).
41. Veeravalli, K. K. et al. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol. Dis. 36, 200-212 (2009).